Physiq

Physiq offers advanced solutions for the healthcare and life sciences industries, focusing on continuous patient monitoring and decentralized clinical trials. Their pinpointIQ platform supports virtual care settings by providing continuous patient monitoring, while accelerateIQ facilitates decentralized clinical trials with continuous remote data collection. Physiq collects four types of data in near real-time: continuous physiological data, survey data via ePRO, patient voice capture, and point measurements, amassing over 4 million hours of on-body patient data. The company holds 19 property patents and has 5 FDA-cleared biomarkers, and has developed 40 proven algorithms backed by over 30 years of experience in machine learning. Physiq provides a comprehensive solution for continuous wearable sensor data, including setup, deployment, and ongoing support, helping pharmaceutical companies and CROs expedite clinical research and bring therapies to market faster. Their solutions support clinicians in managing patients across the entire care continuum, including virtual care and hospital-at-home models. Physiq’s platform collects data from any sensor device and utilizes interactive questionnaires and voice-based anomalies for thorough patient monitoring. The company also offers a partner program called Intrepid to extend its capabilities to CROs, AROs, and other technology solution companies. Physiq provides predictive patient insights and safety through the physIQ Digital Twin and aims to replace traditional treadmill testing with its eVO2Max approach, which uses 24-hour data from wearable sensors to estimate maximum oxygen utilization. Physiq serves clients in over 26 countries and is committed to partnering with leading healthcare, life sciences, and technology companies to build a global healthcare ecosystem. Their medical-grade platform equips clinicians with 24/7 insights to avoid hospital admissions and improve disease management.